Indication (pathologie):
Alzheimer's disease
Identifiant SNOMED-CT:
SCTID 26929004
Etudes cliniques
-
Protocol I8D-MC-AZFD: A randomized, double-blind, delayed-start study of LY3314814 (AZD3293) in early alzheimer’s disease dementia (extension of study AZES, the AMARANTH study)Phase de l'étude: Phase IIIRecrutement: Ouvert
-
A 2-year prospective study to assess health-related quality of life in subjects with highly-active relapsing multiple sclerosis treated with MAVENCLAD®Indication (pathologie):Progressive relapsing multiple sclerosisIdentifiant SNOMED-CT:SCTID 724778008Phase de l'étude: Phase IVRecrutement: Ouvert
-
A prospective, multicenter, observational post-authorization safety study to evaluate the long term safety profile of LEMTRADA® (alemtuzumab) treatment in patients with relapsing forms of multiple sclerosisIndication (pathologie):Multiple sclerosisIdentifiant SNOMED-CT:SCTID 24700007Recrutement: Ouvert
-
A randomized, double-blind, placebo-controlled, dose finding study to evaluate the efficacy and safety of padsevonil as adjunctive treatment of focal-onset seizures in adult subjects with drug-resistant epilepsyIndication (pathologie):EpilepsyIdentifiant SNOMED-CT:SCTID 84757009Phase de l'étude: Phase IIRecrutement: Ouvert
-
Effect of MD1003 in progressive multiple sclerosis: a randomized double blind placebo controlled studyIndication (pathologie):Multiple sclerosisIdentifiant SNOMED-CT:SCTID 24700007Phase de l'étude: Phase IIIRecrutement: Ouvert
-
A multi-centre proof-of-performance clinical study to validate blood-based biomarker candidates for the diagnosis of Alzheimer’s diseaseIndication (pathologie):Alzheimer's diseaseIdentifiant SNOMED-CT:SCTID 26929004Recrutement: Ouvert
-
Proteomic profiling for novel biomarkers of risk of conversion to multiple sclerosis and of disease severityIndication (pathologie):Multiple sclerosisIdentifiant SNOMED-CT:SCTID 24700007Recrutement: Ouvert
-
Investigation par magnétoencéphalographie de l’impact du sommeil lent et des réseaux de neurones associés sur la consolidation de la mémoire et le fonctionnement exécutif chez l’adultes et l’enfant avec ou sans épilepsieIndication (pathologie):EpilepsyIdentifiant SNOMED-CT:SCTID 84757009
-
La quantification de flux artérielle régionale comme outil de décision personnalisé sur la stratégie technique et le choix d’endoprothèse pour les traitements électifs des anévrysmes intracrâniens en NRI"Indication (pathologie):Intracranial aneurysmIdentifiant SNOMED-CT:SCTID 128609009Recrutement: Ouvert
-
Projet de registre des patients atteints des pathologies vasculaires du système nerveux central à risque hémorrhagiqueRecrutement: Ouvert
-
L’enfant face au cancer d’un parent: une étude randomisée évaluant l’efficacité d’une intervention psychologique destinée à soutenir la parentalitéRecrutement: Ouvert
-
Étude prospective non-interventionnelle chez des patients atteints de BPCO et pour qui un traitement avec une trithérapie (ICS/LABA/LAMA) en un seul inhalateur est envisagé (TRIVOLVE)Indication (pathologie):Chronic obstructive lung diseaseIdentifiant SNOMED-CT:13645005Recrutement: Ouvert
-
Efficacy of VX-445 combination therapy in subjects with cystic fibrosis who are homozygous or heterozygous for the f508del mutationIndication (pathologie):Cystic fibrosisIdentifiant SNOMED-CT:190905008Phase de l'étude: Phase IIIRecrutement: Ouvert
-
A phase 3, randomized, double-blind, controlled study evaluating the efficacy and safety of VX-445 combination therapy in subjects with cystic fibrosis who are heterozygous for the F508del mutation and a minimal function mutation (F/MF)Indication (pathologie):Cystic fibrosisIdentifiant SNOMED-CT:190905008Phase de l'étude: Phase IIIRecrutement: Ouvert
-
A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of BG00011 in patients with idiopathic pulmonary fibrosisIndication (pathologie):Idiopathic pulmonary fibrosisIdentifiant SNOMED-CT:700250006Phase de l'étude: Phase IIRecrutement: Ouvert
-
Effets de la réduction endoscopique du volume pulmonaire sur l’endurance à l’effort et l’hyperinflation bronchique chez le patient emphysémateux sévèreIndication (pathologie):Pulmonary emphysemaIdentifiant SNOMED-CT:87433001Recrutement: Ouvert
-
Étude de l'apport de l'analyse protéique du lavage broncho-alvéolaire et du serum dans la mise au point des pathologies pulmonaires interstitielles diffusesIndication (pathologie):Idiopathic pulmonary fibrosisIdentifiant SNOMED-CT:700250006Recrutement: Ouvert
-
Evaluation of CFTR function in cultured organoids from rectal biopsies in patients with cystic fibrosisIndication (pathologie):Cystic fibrosisIdentifiant SNOMED-CT:190905008Recrutement: Ouvert
-
A prospective observational registry to describe the disease course and outcomes of idiopathic pulmonary fibrosis patients in a real-world clinical setting. PROOF-registry new and extended Belgium –LuxembourgIndication (pathologie):Idiopathic pulmonary fibrosisIdentifiant SNOMED-CT:700250006Recrutement: Ouvert
-
A double blind randomized psychoactive placebo-controlled, study to evaluate the efficacy and safety of 3 fixed doses (28mg, 56mg and 84 mg) of intranasal esketamine in addition to comprehensive standard of care for the rapid reduction of the sympoms of major depressive disorder, including suicidal ideation, in pediatric subjects assessed to be at imminent risk of suicideIndication (pathologie):Major depressive disorderIdentifiant SNOMED-CT:370143000Phase de l'étude: Phase IIRecrutement: Ouvert